Effect of ret/PTC 1 rearrangement on transcription and post-transcriptional regulation in a papillary thyroid carcinoma model

Molecular Cancer

Volumn 5, Issue , 2006, Pages

  Cahill, Susanne ^a   Smyth, Paul ^a   Finn, Stephen P ^a   Denning, Karen ^a   Flavin, Richard ^a   O'Regan, Esther M ^a   Li, Jinghuan ^a   Potratz, Astrid ^b   Guenther, Simone M ^b   Henfrey, Richard ^b   O'Leary, John J ^a   Sheils, Orla ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b APPLIED BIOSYSTEMS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN RET;

ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; ENZYME ACTIVATION; GENE EXPRESSION; GENE OVEREXPRESSION; GENE REARRANGEMENT; HUMAN; HUMAN CELL; ONCOGENE; PATHOPHYSIOLOGY; RNA ANALYSIS; THYROID CELL; THYROID PAPILLARY CARCINOMA; TRANSCRIPTION REGULATION; UPREGULATION;

CARCINOMA, PAPILLARY; CELL LINE, TUMOR; GENE EXPRESSION PROFILING; GENE REARRANGEMENT; HUMANS; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCOGENE PROTEINS, FUSION; PROTEIN-TYROSINE KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, MESSENGER; THYROID NEOPLASMS; TRANSCRIPTION, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 33845909583     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-5-70     Document Type: Article

References (49)

1. Takahashi M, Ritz J, Cooper GM: Activation of a novel human transforming gene, ret, by DNA rearrangement. Cell 1985, 42:581-588.
2. Smanik PA, Furminger TL, Mazzaferri EL, Jhiang SM: Breakpoint characterization of the ret/PTC oncogene in human papillary thyroid carcinoma. Hum Mol Genet 1995, 4(12):2313-8.
3. Santoro M, Dathan NA, Berlingieri MT, Bongarzone I, Paulin C, Grieco M, Pierotti MA, Vecchio G, Fusco A: Molecular characterization of RET/PTC3; a novel rearranged version of the RET proto-oncogene in a human thyroid papillary carcinoma. Oncogene 1994, 9(2):509-16.
4. Sheils O: Molecular classification and biomarker discovery in papillary thyroic carcinoma. Expert Rev Mol Diagn 2005, 5(6):927-946.
5. Kondo T, Ezzat S, Asa SL: Pathogenetic mechanisms in thyroid follicular-cell neoplasia. Nat Rev Cancer 2006, 6(4):292-306.
6. Fischer Andrew H, Bond Jane A, Panya Taysavang, Eugene O, David Battles, Thomas Wynford: Papillary Thyroid Carcinoma oncogene (RET/PTC) alters the nuclear envelope and chromatin structure. Am J Pathol 1998, 153:1443-1450.
7. Smyth P, Finn S, Cahill S, O'Regan EM, Flavin R, O'Leary JJ, Sheils O: Ret/PTC and BRAF act as distinct molecular, time dependent triggers in a sporadic Irish cohort of papillary thyroid carcinoma. Int J Surg Pathol 2005, 13:1-8.
8. Giovanni Tallini, Massimo santoro, Mary Helie, Francesca Carlomagno, Giuliana Salvatore, Gennaro Chiappetta, Luisa Carcangiu Maria, Alfredo Fusco: RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumour phenotypes. Clin Cancer Res 1998, 4:287-294.
9. Lee RC, Feinbaum RL, Ambrose V: The C-elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993, 75:843-854.
10. Feinbaum R, Ambrose V: The Timing of lin-4 RNAaccumulation controls the timing of postembryonic developmental events in Caenorhabditis elegans. Dev Biol 1999, 210:87-95.
11. Esquela-Kerscher A, Slack FJ: Oncomirs-MicroRNAs with a role in cancer. Nat Rev Cancer 2006, 6(4):259-269.
12. Sevignani C, Calin GA, Siracusa LD, Croce CM: Mammalian MicroRNAs: a small world for fine-tuning gene expression. Mamm Genome 2006, 17:189-202.
13. Miska EA: How MicroRNAs control cell division, differentiation and death. Curr Opin Genet Dev 2005, 15:563-568.
14. Hwang HW, Mendell JT: MicroRNAs in cell proliferation, cell death and tumourigensis. British J of Cancer 2006, 94:776-780.
15. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M, Croce CM: Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancer. PNAS 2004, 101:2999-3004.
16. Lu J, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz R, Golub TR: MicroRNA expression profiles classify humah cancers. Nature 2005, 435(7043):834-838.
17. Volinia Stefano, Calin George A, Liu Chang-Gong, Ambs Stefan, Cimmino Amelia, Petrocca Fabio, Visone Rosa, Iorio Marilena, Roldo Claudia, Ferracin Manuela, Prueitt Robyn L, Yanaihara Nozumu, Lanza Giovanni, Scarpa Aldo, Vecchione Andrea, Negrini Massimo, Harris Curtis C, Croce Carlo M: A microRNA expression signature of human solid tumours defines cancer gene targets. PNAS 2006, 103:2267-2281.
18. Liu Chang-Gong, Calin George Adrian, Meloon Brian, Gamliel Nir, Sevignani Cinzia, Ferracin Manuela, Dumitru Calin Dan, Shimizu Masayoshi, Zupo Simona, Dono Mariella, Alder Hansjuerg, Bullrich Florencia, Negrini Massimo, Carlo Croce M: An oligonucleotide microchip for genome wide microRNA profiling in human and mouse tissues. PNAS 2004, 101:9740-9744.
19. Hochberg Y, Benjamini Y: More powerful procesdures for multiple significance testing. Stat Med 1990, 9:811-818.
20. Griffiths-Jones Sam, Grocock Russell J, van Dongen Stijn, Bateman Alex, Enright Anton J: miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 2006, 34:140-144.
21. Krek A, Grun D, Poy M, Wolf R, Rosenburg L, Epstein EJ, MacMenamin P, da Piedade I, Grunsalus K, Stoffel M, Rajewsky N: Combinatorial MicroRNA Target Predictions. Nat Genet 2005, 37:495-500.
22. Lewis BP, Shih I, Jones-Rhoades MW, Bartel DP, Burge CB: Prediction of Mammalian MicroRNA Targets. Cell 2003, 115:787-798.
23. Huang Y, Prasad M, Lemon WJ, Hampel H, Wright FA, Kornacker K, LiVolsi V, Frankel W, Kloos RT, Eng C, Pellagata NS, De la Chapella: Gene expression in papillary thyroid carcinoma reveals highly consistent profiles. PNAS 2001, 98:15044-15049.
24. Yano Y, Uematsu N, Yashiro T, Hara H, Ueno E, Miwa M, Tsujimoto G, Aijoshi Y, Uchida K: Gene expression profiling identifies platelet-derived growth factor as a diagnostic molecular marker for papillary thyroid carcinoma. Clin Cancer Res 2004, 10:2035-2043.
25. Finley DJ, Arora N, Zhu B, Gallagher L, Fahey TJ: Molecular profiling distinguishes papillary carcinoma from benign thyroid nodules. J Clin Endocrinol Metab 2004, 89:3214-3223.
26. Jarzab B, Wiench M, Fujarewicz K, Simek K, Jarzab M, Oczko-Wojciechowska M, Wloch J, Czarniecka A, Chmielik E, Lange D, Pawlaczek A, Szpak S, Gubala E, Swierniak A: Gene Expression Profile of Papillary Thyroid Cancer: Sources of Variability and Diagnostic Implications. Cancer Res 2005, 65:1587-1597.
27. Mikita T, Kurama M, Schindler U: Synergistic activation of the germline epsilon promoter mediated by Stat6 and C/EBP beta. J Immunol 1998, 161:1822-8.
28. Pomerance M, Mockey M, Young J, Quillard J, Blondeau JP: Expression, hormonal regulation and subcellular localization of CCAAT/ enhancer-binding protein-beta in rat and human thyrocytes. Thyroid 2006, 15:197-204.
29. Borrello MG, Alberti L, Fischer A, Degl'Innocenti D, Ferrario C, Gariboldi M, Marchesi F, Allavena P, Greco A, Collini P, Pilotti S, Cassinelli G, Bressan P, Fugazzola L, Mantovani A, Pierotti MA: Induction of a proinflammatory program in normal human thyrocytes by the ret/PTC1 oncogene. PNAS 2005, 102(41):14825-14830.
30. Specht MC, Tucker ON, Hocever M, Gonzalez D, Teng L, Fahey TJ 3rd: Cyclooxygenase-2 expression in thyroid nodules. J Clin Endocrinol Metab 2002, 87(1):358-63.
31. Grau S, Richards PJ, Kerr B, Hughes C, Caterson B, Williams AS, Junker U, Jones SA, Clausen T, Ehrmann M: The role of human HTRA1 in arthric disease. J Biol Chem 2006, 281:6124-9.
32. Wasenius VM, Hemmer S, Kettunen E, Knuutila S, Franssile K, Joensuu H: Hepatocyte Growth factor receptor, matrix metalloproteinase-II, tissue inhibitor of metalloproteinase-I and fibronectin are up-regulated in papillary thyroid carcinoma: a cDNA and tissue microarray study. Clin Cancer Res 2003, 9:68-75.
33. Andersson O, Von Euler G: Characterization and expression of the gene encoding membralin, an evolutionary conserved protein expressed in the central nervous system. Brain Res Gene Expr Patterns 2002, 1:205-12.
34. Chen YC, Davidson B, cheng CC, Maitra A, Giuntoli RL 2nd, Hruban RH, Wang TL, Shih IM: Identification and characterisation of membralin a novel tumour associated gene in ovarian carcinoma. Biochem Biophys Acta 2005, 1730(2):96-102.
35. Chu B, Tran K, Ku T, Crowe DL: Regulation of ERK1 gene expression by coactivator proteins. Biochem J 2005, 392:589-599.
36. Raval GN, Bharadwaj S, Levine EA, Willingham MC, Geary RL, Kute T, Prasad GL: Loss of expression of tropomyosin-1, a novel class II tumour suppressor that induces anoikis in primary breast tumours. Oncogene 2003, 22:6194-203.
37. Alto NM, Soderling J, Scott JD: Rab 32 is an A-kinase anchoring protein and participates in mitochondrial dynamics. J Cell Biol 2002, 158:659-68.
38. Shibata D, Mori Y, Cai K, Zang L, Yin J, Elahi A, Hamelin R, Wong YF, Lo WK, Chung TK, Sato F, Karpeh MS Jr, Meltzer SJ: Rab 32 hypermethylation and microsatellite instability in gastric and endometrial adenocarcinoma. Int J Cancer 2006, 119:801-6.
39. Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J, Lee J, Provost P, Radmark O, Kim S, Kim VN: The nuclear RNase III Drosha initiates microRNA processing. Nature 2003, 425:415-9.
40. Irvin-Wilson CV, Chauduri G: Alternative inititiation and splicing in dicer gene expression in human breast cells. Breast Cancer Res 2005, 7(4):563-569.
41. Yanaihara Nozomu, Caplen Natasha, Bowman Elise, Seike Masahiro, Kumamoto Kensuke, Yi Ming, Stephens Robert Y, Okamoto Aikou, Yokota Jun, Tanaka Tadao, Calin George Adrian, Liu Chang-Gong, Croce Carlo M, Harris Curtis C: Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006, 9:189-198.
42. Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H, Harano T, Yatabe Y, Nagino M, Nimura Y, Mitsudomi T, Takahashi T: Reduced expression of the let-7 MicroRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 2004, 64:3753-3756.
43. Calin GA, Liu CG, Sevignani C, Ferracin M, Felli N, Dumitru CD, Shimizu M, Cimmino A, Zupo S, Dono M, Dell'Aquila ML, Alder H, Rassenti L, Kipps TJ, bullrich F, Negrini M, Croce CM: MicroRNA profiling reveals distinct signatures in B cell chronic lymophocytic leukemias. PNAS 2004, 101:11755-11760.
44. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M, Menard S, Palazzo JP, Rosenberg A, Musiani P, Volinia S, Nenci I, Calin GA, Querzoli P, Negrini M, Croce CM: MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005, 65:7065-7070.
45. Ciafre SA, Galardi S, Mangiola A, Ferracin M, Liu CG, Sabatino G, Maira G, Croce CM, Farace MG: Extensive modulation of a set of micrornas in primary glioblastoma. Biochem Biophys Res Commun 2005, 4:1351-8.
46. Bandres E, Cubedo E, Agirre X, Malumbres R, Zarate R, Ramirez N, Abajo A, Navarro A, Moreno I, Monzo M, Garcia-Foncillas J: Identification by real time PCR of 13 mature mirnas differentially expressed in colorectal cancer and nontumoural tissues. Mol Cancer 2006, 5:29.
47. Guimares-Sternburg C, Meerson A, Shaked I, Soreq H: Micro Modulation of megakaryoblast fate involves cholinergic signalling. Leuk Res 2006, 30:583-95.
48. Pallante P, Viscone R, Ferracin M, Ferraro A, Berlingieri MT, Troncone G, Chiappette G, Liu CG, Santoro M, Negrini M, Croce CM, Fusco A: MicroRNA deregulation in human papillary thyroid carcinomas. Endocr Relat Cancer 2006, 13:497-508.
49. Huiling H, Jazdzewski K, Li W, Liyanarachchi S, Nagy R, Volinia S, Calin GA, Liu CG, Franssila K, Suster S, Kloos RT, Croce CM, De la Chapelle A: The role of microRNA genes in papillary thyroid carcinoma. PNAS 2005, 102:19075-19080.